# Human Immunoglobulin

## Human Immunoglobulin 3gm/50mL

| 藥物代碼 | IIG3 |
| :--- | :--- |
| 適應症 | Replacement IgG therapy in primary immunodeficiency, myeloma & chronic lymphatic leukamia with severe secondary hypogammaglobulinemia & recurrent infections, congenital or AIDS with recurrent infections. Immunomodulatory therapy in idiopathic thrombocytopenic purpura \(ITP\) in adults or children at high risk of bleeding or prior to surgery, allogeneic bone marrow transplantation, Kawasaki disease. |
| 副作用 | Malaise, abdominal pain, headache, chest tightness, facial flushing or pallor, erythema, hot sensations, dyspnea or respiratory difficulty, non-urticarial skin rash, cutaneous vasculitis, pompholyx on hands/palms, itching, tissue swelling, change in BP, nausea, vomiting. |
| 禁忌 | Hypersensitivity to human Ig. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | Replacement therapy 0.2-0.6 g/kg/month as a single dose or 2 divided doses at fortnightly intervals. ITP Up to max total cumulative dose of 2 g/kg over 2-5 days. Kawasaki disease 1.6-2 g/kg in divided doses over 2-5 days or 2 g/kg as single dose.Patients should receive concomitant treatment with acetylsalicylic acid. Allogeneic bone marrow transplantation Initially 0.5 g/kg/week. To be administered IV. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer's labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選 仿單建議  【N/S】 可選 仿單建議 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 輸注速率&lt; 4 mL/min;剛開始以1 mL/min，持續15分鐘以上，之後速率可漸增，最高 3-4 mL/min。 |
| 注意事項 | 1. 本注射液可不稀釋直接靜脈輸注，也可用N/S或D5W稀釋後注射。 2. 注射速率從 1 mL/min開始，持續15分鐘以上，之後速率可漸增，最高 3-4 mL/min。 3. 高齡病人及腎臟病病患應考慮使用較低速率給藥。 4. 如發現注射液有混濁或沉澱，或是曾被冷凍過，切勿使用。 |

